Meta Pixel

News and Announcements

Collaborate Corp Ltd Reports a 50% Revenue Increase & $3.5 Million Raised in Outstanding Listed Options

  • Published September 29, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

KEY TAKEAWAYS:

  • Collaborate Corp. Ltd. has released its Annual Report and Business Update where it reported a 50% revenue increase this year.
  • The company raised $3.5 million after it exercised its outstanding CL8 listed options.
  • The company has formed significant partnerships and corporate relations with Subaru, Orix, Uber, RACV and Interleasing.

Collaborate Corporation Ltd. has reported a 50% increase in revenue with much of its growth experience during the latter part of this year. The company recently raised around $3.5 million after it exercised its outstanding CL8 listed options.

This was revealed by Collaborate Corp. Ltd. in its Annual Report and Business Update authorised by CEO and Director Chris Noone.

Collaborate Corp. Ltd., which is headquartered in Sydney, Australia, is a company engaged in the development, marketing and license sales of software. It specialises in peer-to-peer, collaborative consumption and sharing economy businesses. The company operates through Rentoid which includes rent and other platforms, MyCaravan which covers rental business of caravans and DriveMyCar which covers a car rental business.

The company’s stronger financial position is attributed to the significant investments it made in Research and Development. The appointment of several senior executives provided the company with a more experienced team for the execution of its Peer-Pass trust and verification platform as well as its Collaborate marketplaces. It also reported a 32% reduction in corporate and administrative expenses resulting in increased operating efficiency.

Collaborate’s DriveMyCar operations has successfully launched a marketing campaign for Subaru Impreza and has leveraged its relationship with Uber. It was also able to develop new revenue streams for automotive manufacturers and dealers and achieved a 35% reduction in insurance related costs per vehicle.

The MyCaravan operations reported a 150% increase in gross revenue compared to last year’s income. The company developed Mobilise which allowed its clients to generate revenue from their idle assets. Mobilise also partnered with Aon where the latter committed to promote Mobilise to its business clients to help them monetise their ideal assets.

The company has a very positive outlook thanks to increased funding and capitalisation. It also looks forward to a strong collaboration and the development of its corporate relations with Uber, RACV, Orix, Subaru and Interleasing.

Request Information

Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck

Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]

Capital Insights
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.

Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now